Answers are grounded in this paper and cite their sources.
Reason for posting: Major depressive disorders affect one in 10 women of reproductive age, and selective serotonin reuptake inhibitors (SSRIs), with their generally favourable efficacy and safety profiles, are the most common medications used to treat these conditions. However, the results of a
No takes yet. Share an insight, caveat, or question.
Eric Wooltorton (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: